PAM
STRO icon

Panagora Asset Management’s Sutro Biopharma STRO Stock Holding History

Panagora Asset Management’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-14,036
Closed -$91.3K – 1210
2025
Q1 		$91.3K Sell
14,036
-183
-1% -$2.88K ﹤0.01% 1081
2024
Q4 		$262K Sell
14,219
-10,262
-42% -$313K ﹤0.01% 998
2024
Q3 		$847K Sell
24,481
-66,269
-73% -$2.6M ﹤0.01% 774
2024
Q2 		$2.66M Buy
90,750
+12,230
+16% +$484K 0.01% 450
2024
Q1 		$4.44M Buy
78,520
+33,351
+74% +$1.47M 0.02% 365
2023
Q4 		$1.94M Buy
45,169
+8,254
+22% +$262K 0.01% 573
2023
Q3 		$1.28M Buy
36,915
+2,816
+8% +$123K 0.01% 699
2023
Q2 		$1.59M Sell
34,099
-9,099
-21% -$453K 0.01% 621
2023
Q1 		$2M Buy
43,198
+11,900
+38% +$755K 0.01% 574
2022
Q4 		$2.53M Buy
31,298
+5,864
+23% +$408K 0.02% 558
2022
Q3 		$1.41M Buy
25,434
+8,595
+51% +$509K 0.01% 724
2022
Q2 		$877K Buy
16,839
+4,933
+41% +$276K 0.01% 931
2022
Q1 		$979K Sell
11,906
-2,629
-18% -$250K 0.01% 949
2021
Q4 		$2.16M Sell
14,535
-878
-6% -$157K 0.01% 621
2021
Q3 		$2.91M Buy
15,413
+261
+2% +$49.6K 0.02% 569
2021
Q2 		$2.82M Buy
15,152
+8,425
+125% +$1.65M 0.02% 606
2021
Q1 		$1.53M Buy
6,727
+182
+3% +$43.2K 0.01% 848
2020
Q4 		$1.42M Buy
6,545
+2,461
+60% +$407K 0.01% 824
2020
Q3 		$410K Sell
4,084
-79
-2% -$7.46K ﹤0.01% 1250
2020
Q2 		$323K Buy
4,163
+1,935
+87% +$186K ﹤0.01% 1359
2020
Q1 		$227K Buy
2,228
+2,158
+3,083% +$227K ﹤0.01% 1424
2019
Q4 		$8K Hold
70
– – ﹤0.01% 2171
2019
Q3 		$6K Sell
70
-13
-16% -$1.31K ﹤0.01% 2259
2019
Q2 		$9K Buy
+83
New +$9.15K ﹤0.01% 2415

Other funds holding STRO

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
MC
Merck & Co Rahway, New Jersey $526M AUM 175.27% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Panagora Asset Management's STRO Position: Q2 2025 in Review

Panagora Asset Management sold out of Sutro Biopharma (STRO) in Q2 2025, closing a stake of 14,036 shares — an estimated $91.3K sold.

Panagora Asset Management first reported a position in STRO in Q2 2019 and held it in 24 quarters. The position peaked at $4.44M in Q1 2024. 99 funds tracked by Wall St. Rank hold STRO as of Q2 2025.

  • Panagora Asset Management reported no remaining Sutro Biopharma position as of Q2 2025 after selling out during the quarter.
  • Panagora Asset Management sold 14,036 Sutro Biopharma shares in Q2 2025, an estimated $91.3K.
  • Panagora Asset Management first reported a position in Sutro Biopharma in Q2 2019 and held it in 24 quarters.
  • Panagora Asset Management's Sutro Biopharma position peaked at $4.44M in Q1 2024.
  • 99 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2025.

Based on Panagora Asset Management's 13F filing for Q2 2025, filed 13 Aug 2025.